Donate

Industry News

Note: The following is edited from a press release from Shire. Read the full press release in its entirety here.


On December 14, 2017, Shire filed a motion for preliminary injunction against Roche subsidiaries Genentech Inc. and Chugai Pharmaceutical Co., Ltd., as part of an ongoing U.S. patent infringement lawsuit surrounding Genentech/Roche’s emicizumab, currently being marketed as HEMLIBRA.®

Facebook Comments

Sign up for E-mails, Dateline Newsletter, and other ways to stay connected.